A prospective, multicenter, observational study of long-term decitabine treatment in patients with myelodysplastic syndrome

This prospective observational study evaluated the efficacy and safety of long-term decitabine treatment in patients with myelodysplastic syndrome (MDS). Decitabine 20 mg/m(2)/day was administered intravenously for 5 consecutive days every 4 weeks to MDS patients in intermediate-1 or higher Internat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Jeong, Seong Hyun, Kim, Yoo-Jin, Lee, Je-Hwan, Kim, Yeo-Kyeoung, Kim, Soo Jeong, Park, Sung Kyu, Do, Young Rok, Kim, Inho, Mun, Yeung-Chul, Kim, Hoon Gu, Lee, Won Sik, Yi, Hyeon Gyu, Joo, Young-Don, Choi, Chul Won, Kim, Suk Ran, Na, Sang Min, Jang, Jun Ho
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2015
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4792606/
https://ncbi.nlm.nih.gov/pubmed/26517692
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars